Comparative Study between combination therapy Empagliflozin–Sitagliptin and Empagliflozin–Alogliptin in addition to Metformin assessing the hypoglycemic effect on patients diagnosed with malignancy and poorly controlled Type 2 diabetes mellitus as comorbidity. Journal of Carcinogenesis, [S. l.], v. 24, n. 3, p. 669–674, 2025. DOI: 10.64149/J.Carcinog.24.3.669-674. Disponível em: https://carcinogenesis.com/index.php/JOC/article/view/1025. Acesso em: 27 jul. 2026.